Ipca Labs Q1 net loss at Rs 20.25 cr

Updated: Fri, Aug 11, 2017
03:40 pm
PTI
RELATED NEWS
Monetary Policy announcements exhibit continuity and stability - Expert Ajay Bagga tells Anil Singhvi Monetary Policy announcements exhibit continuity and stability - Expert Ajay Bagga tells Anil Singhvi
RBI Monetary Policy Review: Shaktikanta Das led panel keeps policy rates unchanged RBI Monetary Policy Review: Shaktikanta Das led panel keeps policy rates unchanged
Infosys Chairman Nandan Nilekani on India's Digital Economy I Kotak Institutional Equities highlights details Infosys Chairman Nandan Nilekani on India's Digital Economy I Kotak Institutional Equities highlights details

Drug firm Ipca Laboratories today reported a standalone net loss of Rs 20.25 crore for the first quarter ended June, mainly on account of dip in sales in both domestic market and overseas.

The company had posted a net profit of Rs 47.57 crore for the corresponding period of previous fiscal, Ipca Laboratories said in a regulatory filing.

Net total income of the company also declined to Rs 719.14 crore for the quarter under consideration as against Rs 859.54 crore for the same period a year ago.

Income from Indian formulations was down by 17 per cent at Rs 295 crore, while export income dipped by 16 per cent at Rs 371.12 crore, the company said.

Shares of Ipca Laboratories ended 2.40 per cent down at Rs 410.85 on BSE.

 

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.